Beijing Konruns Pharmaceutical Co.,Ltd.

SHSE:603590 Lagerbericht

Marktkapitalisierung: CN¥3.8b

Beijing Konruns PharmaceuticalLtd Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 5/6

Beijing Konruns PharmaceuticalLtd has a total shareholder equity of CN¥3.5B and total debt of CN¥204.7M, which brings its debt-to-equity ratio to 5.8%. Its total assets and total liabilities are CN¥4.0B and CN¥478.6M respectively. Beijing Konruns PharmaceuticalLtd's EBIT is CN¥81.4M making its interest coverage ratio -4.5. It has cash and short-term investments of CN¥640.3M.

Wichtige Informationen

5.8%

Verhältnis von Schulden zu Eigenkapital

CN¥204.68m

Verschuldung

Zinsdeckungsgrad-4.5x
BargeldCN¥640.32m
EigenkapitalCN¥3.52b
GesamtverbindlichkeitenCN¥478.64m
GesamtvermögenCN¥4.00b

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Beijing Konruns Pharmaceutical Co.,Ltd.'s (SHSE:603590) Shares Not Telling The Full Story

Sep 29
Beijing Konruns Pharmaceutical Co.,Ltd.'s (SHSE:603590) Shares Not Telling The Full Story

Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

Sep 03
Concerns Surrounding Beijing Konruns PharmaceuticalLtd's (SHSE:603590) Performance

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 603590's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥319.5M).

Langfristige Verbindlichkeiten: 603590's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥159.2M).


Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 603590 has more cash than its total debt.

Schulden abbauen: 603590's debt to equity ratio has increased from 0% to 5.8% over the past 5 years.

Schuldendeckung: 603590's debt is well covered by operating cash flow (80.5%).

Zinsdeckung: 603590 earns more interest than it pays, so coverage of interest payments is not a concern.


Bilanz


Entdecken Sie finanziell stabile Unternehmen